Anti-NGF Monoclonal Antibodies: The Good, the Bad and the Ugly

Michael Petty, DVM, CCRT, CVPP, MAV

Michael Petty, DVM, is a 1980 graduate of the veterinary school at Michigan State University. As the owner of Arbor Pointe Veterinary Hospital and the Animal Pain Center in Canton, Michigan, he has devoted his professional life to the care and well-being of animals, especially in the area of pain management. Dr Petty is the past president of the International Veterinary Academy of Pain Management. A frequent speaker and consultant, he has published articles in veterinary journals and serves in an advisory capacity to several pharmaceutical companies on pain management. He was also an Elite speaker for Pfizer Animal Health. He has been the investigator and veterinarian in over 12 FDA pilot and pivotal studies for pain-management products. He has lectured internationally on pain management. He is a member of the World Small Animal Veterinary Association Pain Council

Overview:

There is a lot of information about the anti-NGF mabs for both dogs and cats. Some of it is real, some of it is suspect and some of it is false. This webinar explores fact v. fiction of this class of drugs.

Learning Objectives:

Attendees will leave with a better understanding of the facts behind anti-NGF mabs and will better differentiate between areas of concern and areas that are not.
Attendees will be able to bring back knowledge of this topic to share with their colleagues and have a better level of confidence in the use of these drugs. They can then better construct and validate treatment plans for dogs and cats with OA.
This webinar will review and analyze osteoarthritis pain and help differentiate between different treatments to assess the best treatment plans. objectives.

This course is RACE-approved for 1.0 continuing education credits hours in jurisdictions that accept RACE-approval.